Abstract
Different forms of moderately and highly emetogenic cancer chemotherapy that are administered over several days per cycle are discussed with reference to the most efficacious antiemetic therapy. Both preventive and rescue antiemetic therapy are considered.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Basurto C, Rolla F, Tonato M et al (1989) Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. Am J Clin Oncol 12: 235–238
Bremer K on behalf of the granisetron study group (1992) A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy. Eur J Cancer [A] 28: 1018–1022
Buser KS, Joss RA, Piquet D et al (1993) Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind placebocontrolled study. Ann Oncol 4: 474–479
deBoer M, de Wit R, Stoter G, Verweij J (1995) Possible lack of full cross-resistance of 5HT3 antagonists: a pilot study. Cancer Res Clin Oncol 121: 126–127
Depierre A, Lebeau B, Chevallier B et al (1996) Efficay of ondansetron, methylprednisolone plus metopimazine in patients previously incontrolled with dual therapy in cisplatin containing chemotherapy (abstract). Ann Oncol 7: 134
DomÃnguez-Ortega L, Cubedo-Cervera R, Cortés-Funés H, DÃaz-Gallego E (1996) Sleep protects against chemotherapy induces emesis. Cancer 77: 1566–1570
Falkson C, Falkson H (1995) Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy. Oncology 52: 427–431
Fox SM, Einhorn LH, Cox E et al (1993) Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy. J Clin Oncol 11: 2391–2395
Einhorn LH, Naggy C, Werner K et al (1990) Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy. J Clin Oncol 8: 731–735
Hainsworth JD (1992) The use of ondansetron in patients receiving multiple-day cisplatin regimens. Semin Oncol 19: 48–52
Herman TS, Einhorn LH, Jones SE et al (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300: 1295–1297
Italian Group for Antiemetic Research (1992) Ondansetron + dexamethasone versus metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin induced emesis. Lancet 340: 96–99
Levitt M, Warr D,Yelle L et al (1993) Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate and fluorouracil. N Engl J Med 328: 1081–1084
Mantovani G, Macciò A, Alessandro B, Curelli L, Ghiani M, Proto E (1996) Comparison of granisetron versus ondansetron versus tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial. Cancer 77: 941–948
Nicolai N, Mangiarotti B, Salvioni R et al (1993) Dexamethasone plus ondansetron versus dexamethasone plus alizapride in the prevention of emesis induce by cisplatincontaining chemotherapies for urological cancers. Eur Urol 23: 450–456
Rath U, Upadhyaya BK, Arechavala E, et al (1993) Role of ondansetron plus dexamethasone in fractionated chemotherapy. Oncology 50: 168–172
Sledge GW, Einhorn LH, Nagy C et al (1992) Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy. Cancer 70: 2524–2528
Tyson LB, Clark RA, Gralla RJ (1982) High dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial. Cancer Treat Rep 66: 2108
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
De Mulder, P.H.M., Roila, F., Kris, M.G., Marty, M.M. (1998). Consensus Regarding Multiple-Day and Rescue Antiemetic Therapy. In: Gralla, R.J., Tonato, M., Roila, F. (eds) Perugia Consensus Conference on Antiemetic Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72137-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-72137-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72139-7
Online ISBN: 978-3-642-72137-3
eBook Packages: Springer Book Archive